Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
Go back to Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update| GALECTIN (NASDAQ: GALT) | Delayed: 4.06 +0.11 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.95 | 52 Week High | $3.05 | |||
| Open | $3.91 | 52 Week Low | $0.49 | |||
| Day High | $4.08 | P/E | N/A | |||
| Day Low | $3.91 | EPS | $-1.32 | |||
| Volume | 33,247 | |||||

